| Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|
Current Ratio |
0.22 | 0.27 | 0.79 |
Net Debt/EBITDA |
111.92 | 2.41 | 2.18 |
Debt/Assets |
53.77% | 31.08% | 28.71% |
Debt/Equity |
(148.63) | 0.88 | 0.65 |
Asset Turnover |
2.03 | 1.38 | 1.08 |
Operating CF/Net income |
0.05 | (0.23) | (0.92) |
Capex/Depreciation |
(0.15) | (0.05) | (0.11) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (210.89%) | (72.88%) | (17.42%) | |
| (45.07%) | (29.76%) | (7.98%) | |
ROIC |
(73.72%) | (44.82%) | (8.10%) |
Return on Tangible Assets |
90.66% | 102.67% | (430.95%) |
Average Days of Receivables |
9.47 | 8.76 | 8.67 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
34.49% | 33.41% | 30.51% |
Intangible Assets out of Total Assets |
0.66 | 0.75 | 0.77 |
Share Based Compensation of Revenue |
1.45% | 1.02% | 1.51% |
Graham Number |
3.01 | 0.00 | 0.00 |
Free Cash Flow per Share |
(1.61) | 1.37 | 2.10 |
Cash per Share |
0.58 | 1.07 | 2.95 |
Shareholders Equity per Share |
(0.05) | 7.81 | 15.56 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(0.05) | 7.81 | 15.56 |
Free Cash Flow |
(44.99) | 37.71 | 57.74 |
Working Capital |
(289.22) | (261.83) | (38.25) |
Capital Expenditures |
(33.76) | (15.10) | (18.50) |
Net Current Asset Value |
(305.50) | (300.01) | (388.23) |
| Other line items | |||
Quick Ratio |
0.11 | 0.16 | 0.58 |
Depreciation/Fixed assets |
5.48 | 9.89 | 2.96 |
Cash ROIC |
(23.59%) | 4.37% | 2.38% |
Accounts Receivable Turnover |
38.74 | 41.15 | 37.22 |
Accounts Payable Turnover |
9.32 | 9.59 | 9.22 |
Inventory Turnover |
25.01 | 26.79 | 27.81 |
Average Days of Payables |
39.37 | 38.14 | 36.44 |
Days of Inventory on Hand |
15.17 | 13.72 | 12.97 |
Revenue per Share |
36.26 | 39.44 | 40.83 |
Operating CF per Share |
(0.40) | 1.92 | 2.77 |
Capex per Share |
(1.21) | (0.55) | (0.67) |
Average Receivables |
26.18 | 26.34 | 30.14 |
Average Payables |
70.86 | 70.37 | 76.35 |
Average Inventory |
26.40 | 25.18 | 25.30 |
Average Assets |
498.65 | 786.32 | 1,042.02 |
Average Common Equity |
106.56 | 321.13 | 477.63 |
Capex to Sales |
0.03 | 0.01 | 0.02 |
Net Profit Margin |
(22.16%) | (21.59%) | (7.41%) |
Columns are period end dates